Quanterix Corp Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts
ByAinvest
Tuesday, Mar 3, 2026 12:30 am ET1min read
QTRX--
Quanterix Corp reported Q4 2025 revenue of $43.9 million, a 25% YoY increase and 7% sequential growth. However, organic revenue declined by 22% YoY. The company's spatial revenue decreased by 23% YoY, and pharma revenue declined by 21% YoY. Despite this, Quanterix achieved significant milestones with its Lucent AD complete test and launched 13 new assays in 2025. The company is on track to achieve $85 million in cost synergies and reach cash flow breakeven in the second half of 2026.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet